https://hotcopper.com.au/threads/statistical-issues-in-the-analys...

https://hotcopper.com.au/threads/statistical-issues-in-the-analysis-of-bits-p2-trial.4857760/page-6?get_post=true&direction=previous


my post was whether the 2018 results were strong as they said they were. Look after 6 years of no interest from BP, I'm started to question the bold statements made back then. It sounded like Bit 225 was going to cure HIv and other bold calls.

Im no scientist, but when you start reading posts from back in 2018/2019, from people with science / testing backgrounds (see link to a post above) who were actively questioning the potency of results, it makes you wonder whether they were right and the results potentially a failure. See the link at the top.

it does make you wonder what else is going on behind the scenes. I guess we will find out more over the coming months, years. Very interesting stock to follow.


Bit225 patent expires in a few years, which is also another important factor in, there seems to be no concern over this. Seems to be a lot of apathy and "she will be alright" attitude here. No seems want to question things or dig into the detail